Home/Pipeline/Oncology Testing Portfolio

Oncology Testing Portfolio

Various Cancers (Prostate, Breast, Lung, etc.)

CommercialActive

Key Facts

Indication
Various Cancers (Prostate, Breast, Lung, etc.)
Phase
Commercial
Status
Active
Company

About Cambridge Analytical Laboratories

Cambridge Clinical Laboratories (CCL), founded in 2005 and acquired by Source BioScience in April 2025, is a specialised diagnostics service provider based in Cambridge, UK. The company offers a portfolio of UKAS-accredited, personalised healthcare tests, with a strong focus on oncology (e.g., prostate, breast, lung cancer) and molecular diagnostics for healthcare professionals and organisations. Its integration into Source BioScience aims to create an end-to-end laboratory service portfolio, combining genomics, digital pathology, and clinical trial support. CCL's model is exclusively B2B, serving clinicians and healthcare providers to support patient diagnosis, treatment, and monitoring.

View full company profile

Therapeutic Areas